Fundies.
English

VIELA BIO, INC.

EDGAR
VIE Report (type unavailable) · filed 2021-03-15

9 filing records in this dataset, filed from 2019-08-29 to 2021-03-15. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments
Watchlist

Latest quarter

Revenue

9.34 million USD

2020 Q4 · USD

Exact inputs and evidence

Operating margin

-361.31%

2020 Q4 · %

Exact inputs and evidence
  • Operating Income: -153882000 USD Source
  • Operating Income: -120150000 USD Source
  • Revenue: 11652000 USD Source
  • Revenue: 2316000 USD Source

Operating cash flow

-8.46 million USD

2020 Q4 · USD

Exact inputs and evidence
  • Operating Cash Flow: -106113000 USD Source
  • Operating Cash Flow: -97654000 USD Source

Free cash flow

-8.68 million USD

2020 Q4 · USD

Exact inputs and evidence
  • Operating Cash Flow: -106113000 USD Source
  • Operating Cash Flow: -97654000 USD Source
  • Capital Expenditure: 926000 USD Source
  • Capital Expenditure: 704000 USD Source
Cash and cash equivalents
130 million USD Source
Exact value

130065000 USD

Long-term debt including current maturities
Not available
Shares outstanding
54.9 million shares Source
Exact value

54891511 shares

Reported share-count change

8.44% · 4.27 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence
  • 50617868 shares · 2019-12-31· Source
  • 54891511 shares · 2020-12-31· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Net income

-151 million USD

2020-01-01 – 2020-12-31

Exact inputs and evidence
  • Net income: -40777000 USD · 2020-01-01 – 2020-03-31 Source
  • Net income: -38857000 USD · 2020-04-01 – 2020-06-30 Source
  • Net income: -37645000 USD · 2020-07-01 – 2020-09-30 Source
  • Net income: -150668000 USD · 2020-01-01 – 2020-12-31 Source
  • Net income: -117279000 USD · 2020-01-01 – 2020-09-30 Source

Operating cash flow

-106 million USD

2020-01-01 – 2020-12-31

Exact inputs and evidence
  • Operating cash flow: -10871000 USD · 2020-01-01 – 2020-03-31 Source
  • Operating cash flow: -57562000 USD · 2020-01-01 – 2020-06-30 Source
  • Operating cash flow: -10871000 USD · 2020-01-01 – 2020-03-31 Source
  • Operating cash flow: -97654000 USD · 2020-01-01 – 2020-09-30 Source
  • Operating cash flow: -57562000 USD · 2020-01-01 – 2020-06-30 Source
  • Operating cash flow: -106113000 USD · 2020-01-01 – 2020-12-31 Source
  • Operating cash flow: -97654000 USD · 2020-01-01 – 2020-09-30 Source

Capital expenditure

926 thousand USD

2020-01-01 – 2020-12-31

Exact inputs and evidence
  • Capital expenditure: 149000 USD · 2020-01-01 – 2020-03-31 Source
  • Capital expenditure: 296000 USD · 2020-01-01 – 2020-06-30 Source
  • Capital expenditure: 149000 USD · 2020-01-01 – 2020-03-31 Source
  • Capital expenditure: 704000 USD · 2020-01-01 – 2020-09-30 Source
  • Capital expenditure: 296000 USD · 2020-01-01 – 2020-06-30 Source
  • Capital expenditure: 926000 USD · 2020-01-01 – 2020-12-31 Source
  • Capital expenditure: 704000 USD · 2020-01-01 – 2020-09-30 Source

Free cash flow

-107 million USD

2020-01-01 – 2020-12-31

Exact inputs and evidence
  • Operating cash flow: -10871000 USD · 2020-01-01 – 2020-03-31 Source
  • Operating cash flow: -57562000 USD · 2020-01-01 – 2020-06-30 Source
  • Operating cash flow: -10871000 USD · 2020-01-01 – 2020-03-31 Source
  • Operating cash flow: -97654000 USD · 2020-01-01 – 2020-09-30 Source
  • Operating cash flow: -57562000 USD · 2020-01-01 – 2020-06-30 Source
  • Operating cash flow: -106113000 USD · 2020-01-01 – 2020-12-31 Source
  • Operating cash flow: -97654000 USD · 2020-01-01 – 2020-09-30 Source
  • Capital expenditure: 149000 USD · 2020-01-01 – 2020-03-31 Source
  • Capital expenditure: 296000 USD · 2020-01-01 – 2020-06-30 Source
  • Capital expenditure: 149000 USD · 2020-01-01 – 2020-03-31 Source
  • Capital expenditure: 704000 USD · 2020-01-01 – 2020-09-30 Source
  • Capital expenditure: 296000 USD · 2020-01-01 – 2020-06-30 Source
  • Capital expenditure: 926000 USD · 2020-01-01 – 2020-12-31 Source
  • Capital expenditure: 704000 USD · 2020-01-01 – 2020-09-30 Source

Company performance

Up to ten complete financial years · consolidated figures

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2021-03-15.

Financial data available through: 2020-12-31.

Coverage by financial measure
  • Revenue: 2 of 11 periods available· newest 2020-12-31
  • Operating income: 3 of 11 periods available· newest 2020-12-31
  • Net income: 3 of 11 periods available· newest 2020-12-31
  • Operating cash flow: 3 of 11 periods available· newest 2020-12-31
  • Capital expenditure: 3 of 11 periods available· newest 2020-12-31
  • Total assets: 2 of 11 periods available· newest 2020-12-31
  • Total liabilities: 2 of 11 periods available· newest 2020-12-31
  • Current assets: 2 of 11 periods available· newest 2020-12-31
  • Current liabilities: 2 of 11 periods available· newest 2020-12-31
  • Cash and cash equivalents: 2 of 11 periods available· newest 2020-12-31
  • long term debt: No compatible figures in this window
  • Shares outstanding: 2 of 11 periods available· newest 2020-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

  • Revenue

    -76.7%

    Prior period

    USD 50 million

    –

    Current period

    USD 11.65 million

    –

    Exact inputs and evidence

    11652000 − 50000000 = -38348000 USD

    50000000 USD · 2019-01-01 – 2019-12-31

    Inspect prior input Prior source

    11652000 USD · 2020-01-01 – 2020-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Net income

    −USD 64.24 million

    Prior period

    −USD 86.43 million

    –

    Current period

    −USD 150.67 million

    –

    Exact inputs and evidence

    -150668000 − -86429000 = -64239000 USD

    -86429000 USD · 2019-01-01 – 2019-12-31

    Inspect prior input Prior source

    -150668000 USD · 2020-01-01 – 2020-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Operating cash flow

    −USD 1.06 million

    Prior period

    −USD 105.05 million

    –

    Current period

    −USD 106.11 million

    –

    Exact inputs and evidence

    -106113000 − -105049000 = -1064000 USD

    -105049000 USD · 2019-01-01 – 2019-12-31

    Inspect prior input Prior source

    -106113000 USD · 2020-01-01 – 2020-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Capital expenditure

    -15.9%

    Prior period

    USD 1.1 million

    –

    Current period

    USD 926,000

    –

    Exact inputs and evidence

    926000 − 1101000 = -175000 USD

    1101000 USD · 2019-01-01 – 2019-12-31

    Inspect prior input Prior source

    926000 USD · 2020-01-01 – 2020-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2020 2020-01-01 – 2020-12-31

  • Revenue USD 11.65 million 100% of revenue
  • Operating costs Derived USD 165.53 million 1,421% of revenue
  • Operating income −USD 153.88 million −1,321% of revenue
  • Tax, interest and other Derived −USD 3.21 million −28% of revenue
  • Net income −USD 150.67 million −1,293% of revenue

Cash

  • Operating cash flow −USD 106.11 million −911% of revenue
  • Capital expenditure USD 926,000 7.9% of revenue
  • Free cash flow Derived −USD 107.04 million −919% of revenue

Share of revenue by period

  • Net income
  • Tax, interest and other
  • Operating costs
  • 2019 Operating loss: operating costs were 279% of revenue.
  • 2020 Operating loss: operating costs were 1,421% of revenue.
Values and sources
Revenue breakdown by annual reporting period
PeriodRevenueOperating costsOperating incomeTax, interest and otherNet incomeFree cash flowSource
2019 2019-01-01 – 2019-12-3150000000 139691000 Derived -89691000 -3262000 Derived -86429000 -106150000 Derived
Source
2020 2020-01-01 – 2020-12-3111652000 165534000 Derived -153882000 -3214000 Derived -150668000 -107039000 Derived
Source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 11.7M 2020
Revenue historyRevenue reported for each complete financial period. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.54.0M40.5M27.0M13.5M0.020192020
Values and sources
Revenue values and source evidence
PeriodSeriesValue(USD)Source evidence
2019Revenue50000000
2020Revenue11652000

Revenue growth

Change in revenue from the same financial period one year earlier.

-76.7% 2020
Revenue growth historyChange in revenue from the same financial period one year earlier. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.6%-16%-38%-61%-83%20192020
Values and sources
Revenue growth values and source evidence
PeriodSeriesValueSource evidence
2019Year over yearNo prior comparable period
2020Year over year-76.7%

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -1,320.6% 2020
Net margin -1,293.1% 2020
Free cash flow margin -918.6% 2020
Profit margins historyOperating income, net income and free cash flow as a share of revenue. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.106%-277%-660%-1,043%-1,426%20192020
  • Operating margin
  • Net margin
  • Free cash flow margin
Values and sources
Profit margins values and source evidence
PeriodSeriesValueSource evidence
2019Operating margin-179.4%
2020Operating margin-1,320.6%
2019Net margin-172.9%
2020Net margin-1,293.1%
2019Free cash flow margin-212.3%
2020Free cash flow margin-918.6%

Operating cash flow

Cash generated by the company’s normal business operations.

USD -106.1M 2020
Operating cash flow historyCash generated by the company’s normal business operations. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.8.5M-22.3M-53.1M-83.8M-114.6M20192020
Values and sources
Operating cash flow values and source evidence
PeriodSeriesValue(USD)Source evidence
2019Operating cash flow-105049000
2020Operating cash flow-106113000

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -107M 2020
Free cash flow historyOperating cash flow minus capital expenditure for the same period and unit. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.8.6M-22.5M-53.5M-84.6M-115.6M20192020
Values and sources
Free cash flow values and source evidence
PeriodSeriesValue(USD)Source evidence
2019Free cash flow-106150000
2020Free cash flow-107039000

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

11.2% 2020
Liabilities to assets historyTotal liabilities as a share of total assets. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.12.1%9.1%6.1%3.0%0.0%20192020
Values and sources
Liabilities to assets values and source evidence
PeriodSeriesValueSource evidence
2019Liabilities / assets7.7%
2020Liabilities / assets11.2%

Current assets to current liabilities

Current assets divided by current liabilities.

8.45× 2020
Current assets to current liabilities historyCurrent assets divided by current liabilities. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.12.83×9.62×6.42×3.21×0.00×20192020
Values and sources
Current assets to current liabilities values and source evidence
PeriodSeriesValueSource evidence
2019Current assets / current liabilities11.88×
2020Current assets / current liabilities8.45×

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
PeriodNet incomeOperating cash flowCapital expenditureFree cash flow
2018 2018-01-01 – 2018-12-31
−USD 190.27 million
Exact value

Exact value: -190270000 USD

2018-01-01 – 2018-12-31: -190270000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 29.53 million
Exact value

Exact value: -29531000 USD

2018-01-01 – 2018-12-31: -29531000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 491,000
Exact value

Exact value: 491000 USD

2018-01-01 – 2018-12-31: 491000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 30.02 million
Calculation and evidence

-29531000 − 491000 USD

Exact free cash flow: -30022000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2019 2019-01-01 – 2019-12-31
−USD 86.43 million
Exact value

Exact value: -86429000 USD

2019-01-01 – 2019-12-31: -86429000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 105.05 million
Exact value

Exact value: -105049000 USD

2019-01-01 – 2019-12-31: -105049000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 1.1 million
Exact value

Exact value: 1101000 USD

2019-01-01 – 2019-12-31: 1101000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 106.15 million
Calculation and evidence

-105049000 − 1101000 USD

Exact free cash flow: -106150000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2020 2020-01-01 – 2020-12-31
−USD 150.67 million
Exact value

Exact value: -150668000 USD

2020-01-01 – 2020-12-31: -150668000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 106.11 million
Exact value

Exact value: -106113000 USD

2020-01-01 – 2020-12-31: -106113000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 926,000
Exact value

Exact value: 926000 USD

2020-01-01 – 2020-12-31: 926000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 107.04 million
Calculation and evidence

-106113000 − 926000 USD

Exact free cash flow: -107039000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

9 filings · 429 latest values · 429 originally reported values

Dataset published . Source filing dates and reporting periods are shown separately.

Identifiers: 0001734517, 1734517, VIE, edgar:1734517

Also known as VIELA BIO, INC., Viela Bio, Inc.